nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—Citalopram—alcohol dependence	0.412	1	CrCtD
Escitalopram—endogenous depression—Citalopram—alcohol dependence	0.104	0.557	CpDpCtD
Escitalopram—bipolar disorder—Citalopram—alcohol dependence	0.0828	0.443	CpDpCtD
Escitalopram—SLC6A3—alcohol dependence	0.0787	0.572	CbGaD
Escitalopram—SLC6A4—alcohol dependence	0.0589	0.428	CbGaD
Escitalopram—SLC6A3—Citalopram—alcohol dependence	0.0242	0.166	CbGbCtD
Escitalopram—SLC6A4—Citalopram—alcohol dependence	0.0212	0.145	CbGbCtD
Escitalopram—HTR2C—Citalopram—alcohol dependence	0.0177	0.122	CbGbCtD
Escitalopram—SLC6A2—Citalopram—alcohol dependence	0.0177	0.122	CbGbCtD
Escitalopram—CHRM1—Citalopram—alcohol dependence	0.0158	0.108	CbGbCtD
Escitalopram—ADRA1A—Citalopram—alcohol dependence	0.0153	0.105	CbGbCtD
Escitalopram—HRH1—Citalopram—alcohol dependence	0.0133	0.0913	CbGbCtD
Escitalopram—CYP2C19—Citalopram—alcohol dependence	0.007	0.048	CbGbCtD
Escitalopram—CYP2D6—Citalopram—alcohol dependence	0.00532	0.0365	CbGbCtD
Escitalopram—CYP3A4—Disulfiram—alcohol dependence	0.00475	0.0325	CbGbCtD
Escitalopram—CYP3A4—Citalopram—alcohol dependence	0.00338	0.0232	CbGbCtD
Escitalopram—SLC6A2—locus ceruleus—alcohol dependence	0.0013	0.127	CbGeAlD
Escitalopram—SLC6A2—autonomic nervous system—alcohol dependence	0.000691	0.0676	CbGeAlD
Escitalopram—Citalopram—SLC6A3—alcohol dependence	0.000553	0.406	CrCbGaD
Escitalopram—SLC6A3—nerve—alcohol dependence	0.000482	0.0471	CbGeAlD
Escitalopram—Citalopram—SLC6A4—alcohol dependence	0.000413	0.304	CrCbGaD
Escitalopram—Citalopram—CYP2E1—alcohol dependence	0.000396	0.291	CrCbGaD
Escitalopram—SLC6A2—nerve—alcohol dependence	0.000389	0.038	CbGeAlD
Escitalopram—SLC6A3—brainstem—alcohol dependence	0.000207	0.0202	CbGeAlD
Escitalopram—HTR2C—brainstem—alcohol dependence	0.0002	0.0195	CbGeAlD
Escitalopram—SLC6A3—forebrain—alcohol dependence	0.0002	0.0195	CbGeAlD
Escitalopram—HTR2C—forebrain—alcohol dependence	0.000193	0.0189	CbGeAlD
Escitalopram—SLC6A4—brainstem—alcohol dependence	0.000189	0.0185	CbGeAlD
Escitalopram—SLC6A4—forebrain—alcohol dependence	0.000183	0.0179	CbGeAlD
Escitalopram—CHRM1—forebrain—alcohol dependence	0.000182	0.0178	CbGeAlD
Escitalopram—SLC6A2—brainstem—alcohol dependence	0.000167	0.0163	CbGeAlD
Escitalopram—SLC6A2—forebrain—alcohol dependence	0.000161	0.0157	CbGeAlD
Escitalopram—ADRA1A—brainstem—alcohol dependence	0.000155	0.0152	CbGeAlD
Escitalopram—CHRM1—cardiovascular system—alcohol dependence	0.000154	0.0151	CbGeAlD
Escitalopram—ADRA1A—forebrain—alcohol dependence	0.00015	0.0146	CbGeAlD
Escitalopram—SLC6A3—midbrain—alcohol dependence	0.000132	0.0129	CbGeAlD
Escitalopram—SLC6A4—digestive system—alcohol dependence	0.000128	0.0126	CbGeAlD
Escitalopram—HTR2C—midbrain—alcohol dependence	0.000127	0.0125	CbGeAlD
Escitalopram—ADRA1A—cardiovascular system—alcohol dependence	0.000127	0.0124	CbGeAlD
Escitalopram—SLC6A2—gonad—alcohol dependence	0.000124	0.0121	CbGeAlD
Escitalopram—SLC6A4—blood—alcohol dependence	0.000122	0.012	CbGeAlD
Escitalopram—SLC6A4—midbrain—alcohol dependence	0.000121	0.0118	CbGeAlD
Escitalopram—HRH1—forebrain—alcohol dependence	0.000116	0.0113	CbGeAlD
Escitalopram—SLC6A3—testis—alcohol dependence	0.00011	0.0108	CbGeAlD
Escitalopram—SLC6A3—nervous system—alcohol dependence	0.000108	0.0106	CbGeAlD
Escitalopram—CYP2C19—digestive system—alcohol dependence	0.000106	0.0104	CbGeAlD
Escitalopram—SLC6A4—endocrine gland—alcohol dependence	0.000106	0.0104	CbGeAlD
Escitalopram—CHRM1—endocrine gland—alcohol dependence	0.000106	0.0103	CbGeAlD
Escitalopram—HTR2C—nervous system—alcohol dependence	0.000105	0.0102	CbGeAlD
Escitalopram—SLC6A3—central nervous system—alcohol dependence	0.000104	0.0102	CbGeAlD
Escitalopram—SLC6A3—cerebellum—alcohol dependence	0.000102	0.00997	CbGeAlD
Escitalopram—CYP2C19—blood—alcohol dependence	0.000101	0.00991	CbGeAlD
Escitalopram—HTR2C—central nervous system—alcohol dependence	0.000101	0.00986	CbGeAlD
Escitalopram—ADRA1A—blood—alcohol dependence	0.0001	0.00979	CbGeAlD
Escitalopram—SLC6A4—nervous system—alcohol dependence	9.93e-05	0.00971	CbGeAlD
Escitalopram—CHRM1—nervous system—alcohol dependence	9.89e-05	0.00967	CbGeAlD
Escitalopram—SLC6A4—central nervous system—alcohol dependence	9.56e-05	0.00935	CbGeAlD
Escitalopram—CHRM1—central nervous system—alcohol dependence	9.52e-05	0.00931	CbGeAlD
Escitalopram—SLC6A2—endocrine gland—alcohol dependence	9.34e-05	0.00913	CbGeAlD
Escitalopram—CYP2D6—brainstem—alcohol dependence	9.13e-05	0.00893	CbGeAlD
Escitalopram—SLC6A2—testis—alcohol dependence	8.9e-05	0.00871	CbGeAlD
Escitalopram—CYP2D6—forebrain—alcohol dependence	8.81e-05	0.00862	CbGeAlD
Escitalopram—CYP2C19—endocrine gland—alcohol dependence	8.79e-05	0.0086	CbGeAlD
Escitalopram—SLC6A2—nervous system—alcohol dependence	8.74e-05	0.00855	CbGeAlD
Escitalopram—ADRA1A—endocrine gland—alcohol dependence	8.68e-05	0.00849	CbGeAlD
Escitalopram—SLC6A2—central nervous system—alcohol dependence	8.41e-05	0.00823	CbGeAlD
Escitalopram—SLC6A3—brain—alcohol dependence	8.28e-05	0.0081	CbGeAlD
Escitalopram—HRH1—digestive system—alcohol dependence	8.13e-05	0.00795	CbGeAlD
Escitalopram—ADRA1A—nervous system—alcohol dependence	8.12e-05	0.00795	CbGeAlD
Escitalopram—HTR2C—brain—alcohol dependence	8e-05	0.00783	CbGeAlD
Escitalopram—CYP2C19—liver—alcohol dependence	7.92e-05	0.00775	CbGeAlD
Escitalopram—ADRA1A—liver—alcohol dependence	7.83e-05	0.00765	CbGeAlD
Escitalopram—ADRA1A—central nervous system—alcohol dependence	7.82e-05	0.00765	CbGeAlD
Escitalopram—ADRA1A—cerebellum—alcohol dependence	7.64e-05	0.00748	CbGeAlD
Escitalopram—SLC6A4—brain—alcohol dependence	7.59e-05	0.00742	CbGeAlD
Escitalopram—CHRM1—brain—alcohol dependence	7.56e-05	0.00739	CbGeAlD
Escitalopram—HRH1—endocrine gland—alcohol dependence	6.72e-05	0.00657	CbGeAlD
Escitalopram—SLC6A2—brain—alcohol dependence	6.68e-05	0.00653	CbGeAlD
Escitalopram—HRH1—testis—alcohol dependence	6.41e-05	0.00627	CbGeAlD
Escitalopram—HRH1—nervous system—alcohol dependence	6.29e-05	0.00615	CbGeAlD
Escitalopram—CYP3A4—digestive system—alcohol dependence	6.29e-05	0.00615	CbGeAlD
Escitalopram—ADRA1A—brain—alcohol dependence	6.21e-05	0.00607	CbGeAlD
Escitalopram—CYP2D6—digestive system—alcohol dependence	6.19e-05	0.00605	CbGeAlD
Escitalopram—HRH1—central nervous system—alcohol dependence	6.05e-05	0.00592	CbGeAlD
Escitalopram—CYP3A4—blood—alcohol dependence	5.99e-05	0.00586	CbGeAlD
Escitalopram—CYP2D6—blood—alcohol dependence	5.89e-05	0.00577	CbGeAlD
Escitalopram—CYP3A4—endocrine gland—alcohol dependence	5.19e-05	0.00508	CbGeAlD
Escitalopram—CYP2D6—endocrine gland—alcohol dependence	5.11e-05	0.005	CbGeAlD
Escitalopram—CYP2D6—testis—alcohol dependence	4.88e-05	0.00477	CbGeAlD
Escitalopram—CYP3A4—nervous system—alcohol dependence	4.86e-05	0.00476	CbGeAlD
Escitalopram—HRH1—brain—alcohol dependence	4.81e-05	0.0047	CbGeAlD
Escitalopram—CYP2D6—nervous system—alcohol dependence	4.78e-05	0.00468	CbGeAlD
Escitalopram—CYP3A4—liver—alcohol dependence	4.68e-05	0.00458	CbGeAlD
Escitalopram—CYP3A4—central nervous system—alcohol dependence	4.68e-05	0.00458	CbGeAlD
Escitalopram—CYP2D6—liver—alcohol dependence	4.61e-05	0.00451	CbGeAlD
Escitalopram—CYP2D6—central nervous system—alcohol dependence	4.61e-05	0.00451	CbGeAlD
Escitalopram—CYP2D6—cerebellum—alcohol dependence	4.5e-05	0.0044	CbGeAlD
Escitalopram—CYP2D6—brain—alcohol dependence	3.66e-05	0.00358	CbGeAlD
Escitalopram—Angioedema—Acamprosate—alcohol dependence	1.19e-05	0.00014	CcSEcCtD
Escitalopram—Dry skin—Citalopram—alcohol dependence	1.18e-05	0.00014	CcSEcCtD
Escitalopram—Muscle spasms—Naltrexone—alcohol dependence	1.18e-05	0.000139	CcSEcCtD
Escitalopram—Abdominal pain upper—Citalopram—alcohol dependence	1.18e-05	0.000139	CcSEcCtD
Escitalopram—Orthostatic hypotension—Citalopram—alcohol dependence	1.18e-05	0.000139	CcSEcCtD
Escitalopram—Hypokalaemia—Citalopram—alcohol dependence	1.18e-05	0.000139	CcSEcCtD
Escitalopram—Malaise—Acamprosate—alcohol dependence	1.17e-05	0.000138	CcSEcCtD
Escitalopram—Breast disorder—Citalopram—alcohol dependence	1.17e-05	0.000138	CcSEcCtD
Escitalopram—Vertigo—Acamprosate—alcohol dependence	1.17e-05	0.000138	CcSEcCtD
Escitalopram—Syncope—Acamprosate—alcohol dependence	1.16e-05	0.000137	CcSEcCtD
Escitalopram—Toxic epidermal necrolysis—Citalopram—alcohol dependence	1.16e-05	0.000137	CcSEcCtD
Escitalopram—Cramp muscle—Citalopram—alcohol dependence	1.16e-05	0.000137	CcSEcCtD
Escitalopram—Aspartate aminotransferase increased—Citalopram—alcohol dependence	1.16e-05	0.000137	CcSEcCtD
Escitalopram—Leukopenia—Acamprosate—alcohol dependence	1.16e-05	0.000137	CcSEcCtD
Escitalopram—Vision blurred—Naltrexone—alcohol dependence	1.16e-05	0.000137	CcSEcCtD
Escitalopram—Nasopharyngitis—Citalopram—alcohol dependence	1.16e-05	0.000136	CcSEcCtD
Escitalopram—Tremor—Naltrexone—alcohol dependence	1.15e-05	0.000136	CcSEcCtD
Escitalopram—Palpitations—Acamprosate—alcohol dependence	1.15e-05	0.000135	CcSEcCtD
Escitalopram—Gastritis—Citalopram—alcohol dependence	1.14e-05	0.000135	CcSEcCtD
Escitalopram—Loss of consciousness—Acamprosate—alcohol dependence	1.14e-05	0.000135	CcSEcCtD
Escitalopram—Muscular weakness—Citalopram—alcohol dependence	1.14e-05	0.000135	CcSEcCtD
Escitalopram—Alanine aminotransferase increased—Citalopram—alcohol dependence	1.14e-05	0.000135	CcSEcCtD
Escitalopram—Ill-defined disorder—Naltrexone—alcohol dependence	1.14e-05	0.000135	CcSEcCtD
Escitalopram—Cough—Acamprosate—alcohol dependence	1.13e-05	0.000134	CcSEcCtD
Escitalopram—Agitation—Naltrexone—alcohol dependence	1.13e-05	0.000133	CcSEcCtD
Escitalopram—Convulsion—Acamprosate—alcohol dependence	1.12e-05	0.000133	CcSEcCtD
Escitalopram—Abdominal distension—Citalopram—alcohol dependence	1.12e-05	0.000133	CcSEcCtD
Escitalopram—Angioedema—Naltrexone—alcohol dependence	1.12e-05	0.000132	CcSEcCtD
Escitalopram—Hypertension—Acamprosate—alcohol dependence	1.12e-05	0.000132	CcSEcCtD
Escitalopram—Influenza—Citalopram—alcohol dependence	1.12e-05	0.000132	CcSEcCtD
Escitalopram—Asthma—Citalopram—alcohol dependence	1.12e-05	0.000132	CcSEcCtD
Escitalopram—Dysphagia—Citalopram—alcohol dependence	1.12e-05	0.000132	CcSEcCtD
Escitalopram—Malaise—Naltrexone—alcohol dependence	1.11e-05	0.000131	CcSEcCtD
Escitalopram—Eosinophilia—Citalopram—alcohol dependence	1.11e-05	0.000131	CcSEcCtD
Escitalopram—Arthralgia—Acamprosate—alcohol dependence	1.1e-05	0.00013	CcSEcCtD
Escitalopram—Chest pain—Acamprosate—alcohol dependence	1.1e-05	0.00013	CcSEcCtD
Escitalopram—Myalgia—Acamprosate—alcohol dependence	1.1e-05	0.00013	CcSEcCtD
Escitalopram—Syncope—Naltrexone—alcohol dependence	1.1e-05	0.00013	CcSEcCtD
Escitalopram—Anxiety—Acamprosate—alcohol dependence	1.1e-05	0.00013	CcSEcCtD
Escitalopram—Bronchospasm—Citalopram—alcohol dependence	1.1e-05	0.00013	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	1.1e-05	0.00013	CcSEcCtD
Escitalopram—Pancreatitis—Citalopram—alcohol dependence	1.09e-05	0.000129	CcSEcCtD
Escitalopram—Discomfort—Acamprosate—alcohol dependence	1.09e-05	0.000129	CcSEcCtD
Escitalopram—Sweating increased—Citalopram—alcohol dependence	1.09e-05	0.000128	CcSEcCtD
Escitalopram—Angina pectoris—Citalopram—alcohol dependence	1.09e-05	0.000128	CcSEcCtD
Escitalopram—Palpitations—Naltrexone—alcohol dependence	1.09e-05	0.000128	CcSEcCtD
Escitalopram—Dry mouth—Acamprosate—alcohol dependence	1.08e-05	0.000128	CcSEcCtD
Escitalopram—Loss of consciousness—Naltrexone—alcohol dependence	1.08e-05	0.000127	CcSEcCtD
Escitalopram—Bronchitis—Citalopram—alcohol dependence	1.07e-05	0.000127	CcSEcCtD
Escitalopram—Cough—Naltrexone—alcohol dependence	1.07e-05	0.000127	CcSEcCtD
Escitalopram—Abdominal discomfort—Citalopram—alcohol dependence	1.07e-05	0.000126	CcSEcCtD
Escitalopram—Confusional state—Acamprosate—alcohol dependence	1.07e-05	0.000126	CcSEcCtD
Escitalopram—Convulsion—Naltrexone—alcohol dependence	1.06e-05	0.000126	CcSEcCtD
Escitalopram—Pancytopenia—Citalopram—alcohol dependence	1.06e-05	0.000125	CcSEcCtD
Escitalopram—Hypertension—Naltrexone—alcohol dependence	1.06e-05	0.000125	CcSEcCtD
Escitalopram—Anaphylactic shock—Acamprosate—alcohol dependence	1.06e-05	0.000125	CcSEcCtD
Escitalopram—Infection—Acamprosate—alcohol dependence	1.05e-05	0.000124	CcSEcCtD
Escitalopram—Arthralgia—Naltrexone—alcohol dependence	1.05e-05	0.000123	CcSEcCtD
Escitalopram—Chest pain—Naltrexone—alcohol dependence	1.05e-05	0.000123	CcSEcCtD
Escitalopram—Myalgia—Naltrexone—alcohol dependence	1.05e-05	0.000123	CcSEcCtD
Escitalopram—Dysuria—Citalopram—alcohol dependence	1.04e-05	0.000123	CcSEcCtD
Escitalopram—Shock—Acamprosate—alcohol dependence	1.04e-05	0.000123	CcSEcCtD
Escitalopram—Anxiety—Naltrexone—alcohol dependence	1.04e-05	0.000123	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	1.04e-05	0.000123	CcSEcCtD
Escitalopram—Upper respiratory tract infection—Citalopram—alcohol dependence	1.04e-05	0.000123	CcSEcCtD
Escitalopram—Thrombocytopenia—Acamprosate—alcohol dependence	1.04e-05	0.000122	CcSEcCtD
Escitalopram—Tachycardia—Acamprosate—alcohol dependence	1.03e-05	0.000122	CcSEcCtD
Escitalopram—Discomfort—Naltrexone—alcohol dependence	1.03e-05	0.000122	CcSEcCtD
Escitalopram—Pollakiuria—Citalopram—alcohol dependence	1.03e-05	0.000122	CcSEcCtD
Escitalopram—Skin disorder—Acamprosate—alcohol dependence	1.03e-05	0.000121	CcSEcCtD
Escitalopram—Erectile dysfunction—Citalopram—alcohol dependence	1.03e-05	0.000121	CcSEcCtD
Escitalopram—Hyperhidrosis—Acamprosate—alcohol dependence	1.02e-05	0.000121	CcSEcCtD
Escitalopram—Dry mouth—Naltrexone—alcohol dependence	1.02e-05	0.000121	CcSEcCtD
Escitalopram—Photosensitivity reaction—Citalopram—alcohol dependence	1.02e-05	0.00012	CcSEcCtD
Escitalopram—Weight increased—Citalopram—alcohol dependence	1.02e-05	0.00012	CcSEcCtD
Escitalopram—Confusional state—Naltrexone—alcohol dependence	1.01e-05	0.000119	CcSEcCtD
Escitalopram—Weight decreased—Citalopram—alcohol dependence	1.01e-05	0.000119	CcSEcCtD
Escitalopram—Anorexia—Acamprosate—alcohol dependence	1.01e-05	0.000119	CcSEcCtD
Escitalopram—Hyperglycaemia—Citalopram—alcohol dependence	1.01e-05	0.000119	CcSEcCtD
Escitalopram—Oedema—Naltrexone—alcohol dependence	1e-05	0.000118	CcSEcCtD
Escitalopram—Anaphylactic shock—Naltrexone—alcohol dependence	1e-05	0.000118	CcSEcCtD
Escitalopram—Pneumonia—Citalopram—alcohol dependence	1e-05	0.000118	CcSEcCtD
Escitalopram—Infection—Naltrexone—alcohol dependence	9.96e-06	0.000118	CcSEcCtD
Escitalopram—Infestation NOS—Citalopram—alcohol dependence	9.96e-06	0.000118	CcSEcCtD
Escitalopram—Infestation—Citalopram—alcohol dependence	9.96e-06	0.000118	CcSEcCtD
Escitalopram—Depression—Citalopram—alcohol dependence	9.93e-06	0.000117	CcSEcCtD
Escitalopram—Hypotension—Acamprosate—alcohol dependence	9.9e-06	0.000117	CcSEcCtD
Escitalopram—Stevens-Johnson syndrome—Citalopram—alcohol dependence	9.87e-06	0.000117	CcSEcCtD
Escitalopram—Shock—Naltrexone—alcohol dependence	9.86e-06	0.000116	CcSEcCtD
Escitalopram—Nervous system disorder—Naltrexone—alcohol dependence	9.83e-06	0.000116	CcSEcCtD
Escitalopram—Acute coronary syndrome—Citalopram—alcohol dependence	9.81e-06	0.000116	CcSEcCtD
Escitalopram—HTR2C—GPCR downstream signaling—OPRM1—alcohol dependence	9.78e-06	0.000448	CbGpPWpGaD
Escitalopram—Tachycardia—Naltrexone—alcohol dependence	9.78e-06	0.000115	CcSEcCtD
Escitalopram—Neuropathy peripheral—Citalopram—alcohol dependence	9.76e-06	0.000115	CcSEcCtD
Escitalopram—Myocardial infarction—Citalopram—alcohol dependence	9.76e-06	0.000115	CcSEcCtD
Escitalopram—Skin disorder—Naltrexone—alcohol dependence	9.73e-06	0.000115	CcSEcCtD
Escitalopram—Jaundice—Citalopram—alcohol dependence	9.7e-06	0.000115	CcSEcCtD
Escitalopram—Stomatitis—Citalopram—alcohol dependence	9.7e-06	0.000115	CcSEcCtD
Escitalopram—Hyperhidrosis—Naltrexone—alcohol dependence	9.69e-06	0.000114	CcSEcCtD
Escitalopram—Urinary tract infection—Citalopram—alcohol dependence	9.68e-06	0.000114	CcSEcCtD
Escitalopram—Conjunctivitis—Citalopram—alcohol dependence	9.68e-06	0.000114	CcSEcCtD
Escitalopram—HTR2C—Signaling by GPCR—CHRM2—alcohol dependence	9.68e-06	0.000443	CbGpPWpGaD
Escitalopram—Musculoskeletal discomfort—Acamprosate—alcohol dependence	9.65e-06	0.000114	CcSEcCtD
Escitalopram—ADRA1A—GPCR downstream signaling—CRHR1—alcohol dependence	9.64e-06	0.000441	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PDYN—alcohol dependence	9.59e-06	0.000439	CbGpPWpGaD
Escitalopram—Insomnia—Acamprosate—alcohol dependence	9.58e-06	0.000113	CcSEcCtD
Escitalopram—CHRM1—Signaling by GPCR—PDYN—alcohol dependence	9.56e-06	0.000438	CbGpPWpGaD
Escitalopram—Anorexia—Naltrexone—alcohol dependence	9.55e-06	0.000113	CcSEcCtD
Escitalopram—Sweating—Citalopram—alcohol dependence	9.54e-06	0.000113	CcSEcCtD
Escitalopram—Paraesthesia—Acamprosate—alcohol dependence	9.51e-06	0.000112	CcSEcCtD
Escitalopram—Haematuria—Citalopram—alcohol dependence	9.49e-06	0.000112	CcSEcCtD
Escitalopram—Dyspnoea—Acamprosate—alcohol dependence	9.44e-06	0.000112	CcSEcCtD
Escitalopram—Somnolence—Acamprosate—alcohol dependence	9.42e-06	0.000111	CcSEcCtD
Escitalopram—Hepatobiliary disease—Citalopram—alcohol dependence	9.42e-06	0.000111	CcSEcCtD
Escitalopram—ADRA1A—Signaling by GPCR—PDYN—alcohol dependence	9.41e-06	0.000431	CbGpPWpGaD
Escitalopram—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	9.4e-06	0.000431	CbGpPWpGaD
Escitalopram—Epistaxis—Citalopram—alcohol dependence	9.39e-06	0.000111	CcSEcCtD
Escitalopram—Sinusitis—Citalopram—alcohol dependence	9.34e-06	0.00011	CcSEcCtD
Escitalopram—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	9.33e-06	0.000427	CbGpPWpGaD
Escitalopram—Dyspepsia—Acamprosate—alcohol dependence	9.32e-06	0.00011	CcSEcCtD
Escitalopram—Agranulocytosis—Citalopram—alcohol dependence	9.29e-06	0.00011	CcSEcCtD
Escitalopram—HRH1—GPCR downstream signaling—CHRM2—alcohol dependence	9.23e-06	0.000423	CbGpPWpGaD
Escitalopram—Decreased appetite—Acamprosate—alcohol dependence	9.21e-06	0.000109	CcSEcCtD
Escitalopram—CHRM1—GPCR downstream signaling—CHRM2—alcohol dependence	9.2e-06	0.000422	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	9.2e-06	0.000421	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	9.19e-06	0.000421	CbGpPWpGaD
Escitalopram—Gastrointestinal disorder—Acamprosate—alcohol dependence	9.14e-06	0.000108	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Naltrexone—alcohol dependence	9.13e-06	0.000108	CcSEcCtD
Escitalopram—HRH1—GPCR ligand binding—AVP—alcohol dependence	9.13e-06	0.000418	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—AVP—alcohol dependence	9.1e-06	0.000417	CbGpPWpGaD
Escitalopram—Bradycardia—Citalopram—alcohol dependence	9.1e-06	0.000107	CcSEcCtD
Escitalopram—Insomnia—Naltrexone—alcohol dependence	9.06e-06	0.000107	CcSEcCtD
Escitalopram—ADRA1A—GPCR downstream signaling—CHRM2—alcohol dependence	9.06e-06	0.000415	CbGpPWpGaD
Escitalopram—Pain—Acamprosate—alcohol dependence	9.06e-06	0.000107	CcSEcCtD
Escitalopram—Constipation—Acamprosate—alcohol dependence	9.06e-06	0.000107	CcSEcCtD
Escitalopram—HTR2C—GPCR downstream signaling—NPY—alcohol dependence	9e-06	0.000412	CbGpPWpGaD
Escitalopram—Paraesthesia—Naltrexone—alcohol dependence	9e-06	0.000106	CcSEcCtD
Escitalopram—Haemoglobin—Citalopram—alcohol dependence	8.98e-06	0.000106	CcSEcCtD
Escitalopram—CYP2C19—Metabolism—ADH6—alcohol dependence	8.96e-06	0.000411	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—AVP—alcohol dependence	8.96e-06	0.00041	CbGpPWpGaD
Escitalopram—Rhinitis—Citalopram—alcohol dependence	8.96e-06	0.000106	CcSEcCtD
Escitalopram—ADRA1A—GPCR ligand binding—AVP—alcohol dependence	8.96e-06	0.00041	CbGpPWpGaD
Escitalopram—Hepatitis—Citalopram—alcohol dependence	8.94e-06	0.000106	CcSEcCtD
Escitalopram—Haemorrhage—Citalopram—alcohol dependence	8.94e-06	0.000106	CcSEcCtD
Escitalopram—Dyspnoea—Naltrexone—alcohol dependence	8.93e-06	0.000106	CcSEcCtD
Escitalopram—HRH1—Signaling by GPCR—CRHR1—alcohol dependence	8.92e-06	0.000408	CbGpPWpGaD
Escitalopram—Somnolence—Naltrexone—alcohol dependence	8.91e-06	0.000105	CcSEcCtD
Escitalopram—Hypoaesthesia—Citalopram—alcohol dependence	8.89e-06	0.000105	CcSEcCtD
Escitalopram—Hallucination—Citalopram—alcohol dependence	8.89e-06	0.000105	CcSEcCtD
Escitalopram—CHRM1—Signaling by GPCR—CRHR1—alcohol dependence	8.89e-06	0.000407	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—OPRM1—alcohol dependence	8.88e-06	0.000407	CbGpPWpGaD
Escitalopram—Pharyngitis—Citalopram—alcohol dependence	8.87e-06	0.000105	CcSEcCtD
Escitalopram—Urinary tract disorder—Citalopram—alcohol dependence	8.83e-06	0.000104	CcSEcCtD
Escitalopram—Oedema peripheral—Citalopram—alcohol dependence	8.8e-06	0.000104	CcSEcCtD
Escitalopram—HRH1—Signaling Pathways—OPRK1—alcohol dependence	8.79e-06	0.000403	CbGpPWpGaD
Escitalopram—Connective tissue disorder—Citalopram—alcohol dependence	8.78e-06	0.000104	CcSEcCtD
Escitalopram—HTR2C—GPCR ligand binding—HTR2A—alcohol dependence	8.77e-06	0.000401	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—OPRK1—alcohol dependence	8.77e-06	0.000401	CbGpPWpGaD
Escitalopram—Urethral disorder—Citalopram—alcohol dependence	8.76e-06	0.000103	CcSEcCtD
Escitalopram—ADRA1A—Signaling by GPCR—CRHR1—alcohol dependence	8.75e-06	0.000401	CbGpPWpGaD
Escitalopram—Feeling abnormal—Acamprosate—alcohol dependence	8.73e-06	0.000103	CcSEcCtD
Escitalopram—Decreased appetite—Naltrexone—alcohol dependence	8.71e-06	0.000103	CcSEcCtD
Escitalopram—HTR2C—GPCR downstream signaling—HTR1B—alcohol dependence	8.69e-06	0.000398	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CRH—alcohol dependence	8.69e-06	0.000398	CbGpPWpGaD
Escitalopram—Gastrointestinal pain—Acamprosate—alcohol dependence	8.66e-06	0.000102	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Naltrexone—alcohol dependence	8.65e-06	0.000102	CcSEcCtD
Escitalopram—Fatigue—Naltrexone—alcohol dependence	8.64e-06	0.000102	CcSEcCtD
Escitalopram—ADRA1A—Signaling Pathways—OPRK1—alcohol dependence	8.63e-06	0.000395	CbGpPWpGaD
Escitalopram—Visual impairment—Citalopram—alcohol dependence	8.61e-06	0.000102	CcSEcCtD
Escitalopram—Constipation—Naltrexone—alcohol dependence	8.57e-06	0.000101	CcSEcCtD
Escitalopram—Pain—Naltrexone—alcohol dependence	8.57e-06	0.000101	CcSEcCtD
Escitalopram—CYP3A4—Biological oxidations—GGT1—alcohol dependence	8.56e-06	0.000392	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—OPRM1—alcohol dependence	8.48e-06	0.000388	CbGpPWpGaD
Escitalopram—Erythema multiforme—Citalopram—alcohol dependence	8.45e-06	9.98e-05	CcSEcCtD
Escitalopram—CHRM1—GPCR downstream signaling—OPRM1—alcohol dependence	8.45e-06	0.000387	CbGpPWpGaD
Escitalopram—Urticaria—Acamprosate—alcohol dependence	8.41e-06	9.94e-05	CcSEcCtD
Escitalopram—HRH1—Signaling by GPCR—CHRM2—alcohol dependence	8.38e-06	0.000384	CbGpPWpGaD
Escitalopram—Body temperature increased—Acamprosate—alcohol dependence	8.37e-06	9.89e-05	CcSEcCtD
Escitalopram—Abdominal pain—Acamprosate—alcohol dependence	8.37e-06	9.89e-05	CcSEcCtD
Escitalopram—CHRM1—Signaling by GPCR—CHRM2—alcohol dependence	8.36e-06	0.000383	CbGpPWpGaD
Escitalopram—Eye disorder—Citalopram—alcohol dependence	8.35e-06	9.86e-05	CcSEcCtD
Escitalopram—Tinnitus—Citalopram—alcohol dependence	8.33e-06	9.84e-05	CcSEcCtD
Escitalopram—ADRA1A—GPCR downstream signaling—OPRM1—alcohol dependence	8.32e-06	0.000381	CbGpPWpGaD
Escitalopram—CYP2C19—Biological oxidations—POMC—alcohol dependence	8.31e-06	0.00038	CbGpPWpGaD
Escitalopram—Flushing—Citalopram—alcohol dependence	8.29e-06	9.79e-05	CcSEcCtD
Escitalopram—Cardiac disorder—Citalopram—alcohol dependence	8.29e-06	9.79e-05	CcSEcCtD
Escitalopram—Feeling abnormal—Naltrexone—alcohol dependence	8.26e-06	9.75e-05	CcSEcCtD
Escitalopram—CYP2D6—Metabolism—ADH6—alcohol dependence	8.24e-06	0.000378	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CHRM2—alcohol dependence	8.23e-06	0.000377	CbGpPWpGaD
Escitalopram—Gastrointestinal pain—Naltrexone—alcohol dependence	8.19e-06	9.68e-05	CcSEcCtD
Escitalopram—HTR2C—Signaling by GPCR—NPY—alcohol dependence	8.18e-06	0.000374	CbGpPWpGaD
Escitalopram—Angiopathy—Citalopram—alcohol dependence	8.11e-06	9.58e-05	CcSEcCtD
Escitalopram—Immune system disorder—Citalopram—alcohol dependence	8.07e-06	9.53e-05	CcSEcCtD
Escitalopram—Mediastinal disorder—Citalopram—alcohol dependence	8.05e-06	9.51e-05	CcSEcCtD
Escitalopram—Chills—Citalopram—alcohol dependence	8.02e-06	9.47e-05	CcSEcCtD
Escitalopram—Arrhythmia—Citalopram—alcohol dependence	7.98e-06	9.43e-05	CcSEcCtD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	7.97e-06	0.000365	CbGpPWpGaD
Escitalopram—Urticaria—Naltrexone—alcohol dependence	7.96e-06	9.4e-05	CcSEcCtD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	7.94e-06	0.000364	CbGpPWpGaD
Escitalopram—Body temperature increased—Naltrexone—alcohol dependence	7.92e-06	9.35e-05	CcSEcCtD
Escitalopram—Abdominal pain—Naltrexone—alcohol dependence	7.92e-06	9.35e-05	CcSEcCtD
Escitalopram—Alopecia—Citalopram—alcohol dependence	7.9e-06	9.33e-05	CcSEcCtD
Escitalopram—HTR2C—Signaling by GPCR—HTR1B—alcohol dependence	7.89e-06	0.000361	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CRH—alcohol dependence	7.89e-06	0.000361	CbGpPWpGaD
Escitalopram—Mental disorder—Citalopram—alcohol dependence	7.83e-06	9.25e-05	CcSEcCtD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	7.82e-06	0.000358	CbGpPWpGaD
Escitalopram—Hypersensitivity—Acamprosate—alcohol dependence	7.8e-06	9.21e-05	CcSEcCtD
Escitalopram—HRH1—GPCR downstream signaling—NPY—alcohol dependence	7.8e-06	0.000357	CbGpPWpGaD
Escitalopram—Erythema—Citalopram—alcohol dependence	7.78e-06	9.19e-05	CcSEcCtD
Escitalopram—Malnutrition—Citalopram—alcohol dependence	7.78e-06	9.19e-05	CcSEcCtD
Escitalopram—CHRM1—GPCR downstream signaling—NPY—alcohol dependence	7.78e-06	0.000356	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—OPRM1—alcohol dependence	7.7e-06	0.000353	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—OPRM1—alcohol dependence	7.67e-06	0.000351	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—MAOA—alcohol dependence	7.67e-06	0.000351	CbGpPWpGaD
Escitalopram—Flatulence—Citalopram—alcohol dependence	7.67e-06	9.05e-05	CcSEcCtD
Escitalopram—ADRA1A—GPCR downstream signaling—NPY—alcohol dependence	7.65e-06	0.000351	CbGpPWpGaD
Escitalopram—CYP2D6—Biological oxidations—POMC—alcohol dependence	7.64e-06	0.00035	CbGpPWpGaD
Escitalopram—Tension—Citalopram—alcohol dependence	7.63e-06	9.02e-05	CcSEcCtD
Escitalopram—Dysgeusia—Citalopram—alcohol dependence	7.62e-06	9e-05	CcSEcCtD
Escitalopram—Asthenia—Acamprosate—alcohol dependence	7.6e-06	8.97e-05	CcSEcCtD
Escitalopram—HRH1—GPCR ligand binding—HTR2A—alcohol dependence	7.6e-06	0.000348	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—DRD4—alcohol dependence	7.59e-06	0.000348	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—HTR2A—alcohol dependence	7.57e-06	0.000347	CbGpPWpGaD
Escitalopram—Nervousness—Citalopram—alcohol dependence	7.56e-06	8.92e-05	CcSEcCtD
Escitalopram—ADRA1A—Signaling by GPCR—OPRM1—alcohol dependence	7.55e-06	0.000346	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—HTR1B—alcohol dependence	7.53e-06	0.000345	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CRH—alcohol dependence	7.53e-06	0.000345	CbGpPWpGaD
Escitalopram—Back pain—Citalopram—alcohol dependence	7.53e-06	8.89e-05	CcSEcCtD
Escitalopram—CHRM1—Circadian rythm related genes—EP300—alcohol dependence	7.51e-06	0.000344	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CRH—alcohol dependence	7.5e-06	0.000344	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—HTR1B—alcohol dependence	7.5e-06	0.000344	CbGpPWpGaD
Escitalopram—Pruritus—Acamprosate—alcohol dependence	7.49e-06	8.85e-05	CcSEcCtD
Escitalopram—Muscle spasms—Citalopram—alcohol dependence	7.48e-06	8.83e-05	CcSEcCtD
Escitalopram—ADRA1A—GPCR ligand binding—HTR2A—alcohol dependence	7.45e-06	0.000341	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ADH1A—alcohol dependence	7.43e-06	0.00034	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CRH—alcohol dependence	7.39e-06	0.000338	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—HTR1B—alcohol dependence	7.39e-06	0.000338	CbGpPWpGaD
Escitalopram—Hypersensitivity—Naltrexone—alcohol dependence	7.38e-06	8.72e-05	CcSEcCtD
Escitalopram—Vision blurred—Citalopram—alcohol dependence	7.33e-06	8.66e-05	CcSEcCtD
Escitalopram—Tremor—Citalopram—alcohol dependence	7.29e-06	8.61e-05	CcSEcCtD
Escitalopram—HTR2C—GPCR downstream signaling—CNR1—alcohol dependence	7.25e-06	0.000332	CbGpPWpGaD
Escitalopram—Diarrhoea—Acamprosate—alcohol dependence	7.25e-06	8.56e-05	CcSEcCtD
Escitalopram—Ill-defined disorder—Citalopram—alcohol dependence	7.22e-06	8.52e-05	CcSEcCtD
Escitalopram—Anaemia—Citalopram—alcohol dependence	7.19e-06	8.49e-05	CcSEcCtD
Escitalopram—Asthenia—Naltrexone—alcohol dependence	7.19e-06	8.49e-05	CcSEcCtD
Escitalopram—Agitation—Citalopram—alcohol dependence	7.15e-06	8.44e-05	CcSEcCtD
Escitalopram—Angioedema—Citalopram—alcohol dependence	7.11e-06	8.39e-05	CcSEcCtD
Escitalopram—Pruritus—Naltrexone—alcohol dependence	7.09e-06	8.37e-05	CcSEcCtD
Escitalopram—HRH1—Signaling by GPCR—NPY—alcohol dependence	7.08e-06	0.000324	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—DRD2—alcohol dependence	7.07e-06	0.000324	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—HTR7—alcohol dependence	7.07e-06	0.000324	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—NPY—alcohol dependence	7.06e-06	0.000323	CbGpPWpGaD
Escitalopram—Malaise—Citalopram—alcohol dependence	7.02e-06	8.28e-05	CcSEcCtD
Escitalopram—Dizziness—Acamprosate—alcohol dependence	7e-06	8.27e-05	CcSEcCtD
Escitalopram—HTR2C—GPCR ligand binding—POMC—alcohol dependence	7e-06	0.000321	CbGpPWpGaD
Escitalopram—Vertigo—Citalopram—alcohol dependence	6.99e-06	8.25e-05	CcSEcCtD
Escitalopram—Syncope—Citalopram—alcohol dependence	6.98e-06	8.24e-05	CcSEcCtD
Escitalopram—Leukopenia—Citalopram—alcohol dependence	6.96e-06	8.22e-05	CcSEcCtD
Escitalopram—ADRA1A—Signaling by GPCR—NPY—alcohol dependence	6.95e-06	0.000318	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—DRD4—alcohol dependence	6.89e-06	0.000316	CbGpPWpGaD
Escitalopram—Palpitations—Citalopram—alcohol dependence	6.87e-06	8.12e-05	CcSEcCtD
Escitalopram—Diarrhoea—Naltrexone—alcohol dependence	6.86e-06	8.1e-05	CcSEcCtD
Escitalopram—Loss of consciousness—Citalopram—alcohol dependence	6.84e-06	8.07e-05	CcSEcCtD
Escitalopram—HRH1—Signaling by GPCR—CRH—alcohol dependence	6.83e-06	0.000313	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HTR1B—alcohol dependence	6.83e-06	0.000313	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ADH1A—alcohol dependence	6.83e-06	0.000313	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—OPRD1—alcohol dependence	6.82e-06	0.000312	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CRH—alcohol dependence	6.81e-06	0.000312	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HTR1B—alcohol dependence	6.81e-06	0.000312	CbGpPWpGaD
Escitalopram—Cough—Citalopram—alcohol dependence	6.79e-06	8.02e-05	CcSEcCtD
Escitalopram—Convulsion—Citalopram—alcohol dependence	6.74e-06	7.96e-05	CcSEcCtD
Escitalopram—Vomiting—Acamprosate—alcohol dependence	6.73e-06	7.95e-05	CcSEcCtD
Escitalopram—Hypertension—Citalopram—alcohol dependence	6.72e-06	7.93e-05	CcSEcCtD
Escitalopram—ADRA1A—Signaling by GPCR—HTR1B—alcohol dependence	6.71e-06	0.000307	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CRH—alcohol dependence	6.71e-06	0.000307	CbGpPWpGaD
Escitalopram—Rash—Acamprosate—alcohol dependence	6.68e-06	7.89e-05	CcSEcCtD
Escitalopram—Dermatitis—Acamprosate—alcohol dependence	6.67e-06	7.88e-05	CcSEcCtD
Escitalopram—Headache—Acamprosate—alcohol dependence	6.64e-06	7.84e-05	CcSEcCtD
Escitalopram—Dizziness—Naltrexone—alcohol dependence	6.63e-06	7.83e-05	CcSEcCtD
Escitalopram—Myalgia—Citalopram—alcohol dependence	6.62e-06	7.82e-05	CcSEcCtD
Escitalopram—Chest pain—Citalopram—alcohol dependence	6.62e-06	7.82e-05	CcSEcCtD
Escitalopram—Arthralgia—Citalopram—alcohol dependence	6.62e-06	7.82e-05	CcSEcCtD
Escitalopram—Anxiety—Citalopram—alcohol dependence	6.6e-06	7.79e-05	CcSEcCtD
Escitalopram—HTR2C—Signaling by GPCR—CNR1—alcohol dependence	6.58e-06	0.000302	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—DRD4—alcohol dependence	6.58e-06	0.000301	CbGpPWpGaD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	6.58e-06	7.77e-05	CcSEcCtD
Escitalopram—CHRM1—GPCR downstream signaling—DRD4—alcohol dependence	6.56e-06	0.0003	CbGpPWpGaD
Escitalopram—Discomfort—Citalopram—alcohol dependence	6.54e-06	7.73e-05	CcSEcCtD
Escitalopram—HTR2C—Signaling Pathways—PDYN—alcohol dependence	6.54e-06	0.0003	CbGpPWpGaD
Escitalopram—Dry mouth—Citalopram—alcohol dependence	6.48e-06	7.65e-05	CcSEcCtD
Escitalopram—ADRA1A—GPCR downstream signaling—DRD4—alcohol dependence	6.46e-06	0.000296	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—DRD2—alcohol dependence	6.42e-06	0.000294	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—HTR7—alcohol dependence	6.42e-06	0.000294	CbGpPWpGaD
Escitalopram—Confusional state—Citalopram—alcohol dependence	6.4e-06	7.56e-05	CcSEcCtD
Escitalopram—Vomiting—Naltrexone—alcohol dependence	6.37e-06	7.52e-05	CcSEcCtD
Escitalopram—Oedema—Citalopram—alcohol dependence	6.35e-06	7.5e-05	CcSEcCtD
Escitalopram—Anaphylactic shock—Citalopram—alcohol dependence	6.35e-06	7.5e-05	CcSEcCtD
Escitalopram—Rash—Naltrexone—alcohol dependence	6.32e-06	7.46e-05	CcSEcCtD
Escitalopram—CYP2C19—Metabolism—ADH4—alcohol dependence	6.32e-06	0.000289	CbGpPWpGaD
Escitalopram—Dermatitis—Naltrexone—alcohol dependence	6.31e-06	7.45e-05	CcSEcCtD
Escitalopram—Infection—Citalopram—alcohol dependence	6.31e-06	7.45e-05	CcSEcCtD
Escitalopram—Nausea—Acamprosate—alcohol dependence	6.29e-06	7.43e-05	CcSEcCtD
Escitalopram—HRH1—GPCR downstream signaling—CNR1—alcohol dependence	6.28e-06	0.000288	CbGpPWpGaD
Escitalopram—Headache—Naltrexone—alcohol dependence	6.28e-06	7.41e-05	CcSEcCtD
Escitalopram—CHRM1—GPCR downstream signaling—CNR1—alcohol dependence	6.26e-06	0.000287	CbGpPWpGaD
Escitalopram—Shock—Citalopram—alcohol dependence	6.25e-06	7.38e-05	CcSEcCtD
Escitalopram—Nervous system disorder—Citalopram—alcohol dependence	6.23e-06	7.35e-05	CcSEcCtD
Escitalopram—Thrombocytopenia—Citalopram—alcohol dependence	6.22e-06	7.34e-05	CcSEcCtD
Escitalopram—Tachycardia—Citalopram—alcohol dependence	6.2e-06	7.32e-05	CcSEcCtD
Escitalopram—Skin disorder—Citalopram—alcohol dependence	6.17e-06	7.28e-05	CcSEcCtD
Escitalopram—ADRA1A—GPCR downstream signaling—CNR1—alcohol dependence	6.16e-06	0.000282	CbGpPWpGaD
Escitalopram—Hyperhidrosis—Citalopram—alcohol dependence	6.14e-06	7.25e-05	CcSEcCtD
Escitalopram—HRH1—GPCR downstream signaling—DRD2—alcohol dependence	6.13e-06	0.000281	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—HTR7—alcohol dependence	6.13e-06	0.000281	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—DRD2—alcohol dependence	6.11e-06	0.00028	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—HTR7—alcohol dependence	6.11e-06	0.00028	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—WASF2—alcohol dependence	6.08e-06	0.000278	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CRHR1—alcohol dependence	6.08e-06	0.000278	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—POMC—alcohol dependence	6.07e-06	0.000278	CbGpPWpGaD
Escitalopram—Anorexia—Citalopram—alcohol dependence	6.05e-06	7.15e-05	CcSEcCtD
Escitalopram—CHRM1—GPCR ligand binding—POMC—alcohol dependence	6.05e-06	0.000277	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—DRD2—alcohol dependence	6.01e-06	0.000275	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—HTR7—alcohol dependence	6.01e-06	0.000275	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—DRD4—alcohol dependence	5.97e-06	0.000274	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—DRD4—alcohol dependence	5.95e-06	0.000273	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—AVP—alcohol dependence	5.95e-06	0.000273	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—POMC—alcohol dependence	5.95e-06	0.000273	CbGpPWpGaD
Escitalopram—Nausea—Naltrexone—alcohol dependence	5.95e-06	7.03e-05	CcSEcCtD
Escitalopram—Hypotension—Citalopram—alcohol dependence	5.93e-06	7.01e-05	CcSEcCtD
Escitalopram—HRH1—Signaling Pathways—OPRD1—alcohol dependence	5.91e-06	0.000271	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—OPRD1—alcohol dependence	5.89e-06	0.00027	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—DRD4—alcohol dependence	5.86e-06	0.000269	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—WASF1—alcohol dependence	5.83e-06	0.000267	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ADH4—alcohol dependence	5.81e-06	0.000266	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—OPRD1—alcohol dependence	5.8e-06	0.000266	CbGpPWpGaD
Escitalopram—Musculoskeletal discomfort—Citalopram—alcohol dependence	5.78e-06	6.83e-05	CcSEcCtD
Escitalopram—Insomnia—Citalopram—alcohol dependence	5.74e-06	6.78e-05	CcSEcCtD
Escitalopram—HTR2C—Signaling Pathways—CHRM2—alcohol dependence	5.72e-06	0.000262	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CNR1—alcohol dependence	5.7e-06	0.000261	CbGpPWpGaD
Escitalopram—Paraesthesia—Citalopram—alcohol dependence	5.7e-06	6.73e-05	CcSEcCtD
Escitalopram—CHRM1—Signaling by GPCR—CNR1—alcohol dependence	5.69e-06	0.00026	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PDYN—alcohol dependence	5.67e-06	0.00026	CbGpPWpGaD
Escitalopram—Dyspnoea—Citalopram—alcohol dependence	5.66e-06	6.68e-05	CcSEcCtD
Escitalopram—CHRM1—Signaling Pathways—PDYN—alcohol dependence	5.65e-06	0.000259	CbGpPWpGaD
Escitalopram—Somnolence—Citalopram—alcohol dependence	5.64e-06	6.67e-05	CcSEcCtD
Escitalopram—ADRA1A—Signaling by GPCR—CNR1—alcohol dependence	5.6e-06	0.000256	CbGpPWpGaD
Escitalopram—Dyspepsia—Citalopram—alcohol dependence	5.59e-06	6.6e-05	CcSEcCtD
Escitalopram—HRH1—Signaling by GPCR—DRD2—alcohol dependence	5.57e-06	0.000255	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HTR7—alcohol dependence	5.57e-06	0.000255	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PDYN—alcohol dependence	5.56e-06	0.000255	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—DRD2—alcohol dependence	5.55e-06	0.000254	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HTR7—alcohol dependence	5.55e-06	0.000254	CbGpPWpGaD
Escitalopram—Decreased appetite—Citalopram—alcohol dependence	5.52e-06	6.52e-05	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Citalopram—alcohol dependence	5.48e-06	6.47e-05	CcSEcCtD
Escitalopram—Fatigue—Citalopram—alcohol dependence	5.47e-06	6.46e-05	CcSEcCtD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	5.47e-06	0.00025	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HTR7—alcohol dependence	5.46e-06	0.00025	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—DRD2—alcohol dependence	5.46e-06	0.00025	CbGpPWpGaD
Escitalopram—Pain—Citalopram—alcohol dependence	5.43e-06	6.41e-05	CcSEcCtD
Escitalopram—Constipation—Citalopram—alcohol dependence	5.43e-06	6.41e-05	CcSEcCtD
Escitalopram—HTR2C—Signaling by GPCR—AVP—alcohol dependence	5.41e-06	0.000248	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ADH6—alcohol dependence	5.39e-06	0.000247	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ADH7—alcohol dependence	5.37e-06	0.000246	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—WASF2—alcohol dependence	5.27e-06	0.000241	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CRHR1—alcohol dependence	5.27e-06	0.000241	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—WASF2—alcohol dependence	5.25e-06	0.000241	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CRHR1—alcohol dependence	5.25e-06	0.000241	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—OPRM1—alcohol dependence	5.25e-06	0.00024	CbGpPWpGaD
Escitalopram—Feeling abnormal—Citalopram—alcohol dependence	5.23e-06	6.18e-05	CcSEcCtD
Escitalopram—Gastrointestinal pain—Citalopram—alcohol dependence	5.19e-06	6.13e-05	CcSEcCtD
Escitalopram—ADRA1A—Signaling Pathways—WASF2—alcohol dependence	5.17e-06	0.000237	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CRHR1—alcohol dependence	5.17e-06	0.000237	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—AVP—alcohol dependence	5.16e-06	0.000236	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GGT2—alcohol dependence	5.15e-06	0.000236	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—AVP—alcohol dependence	5.14e-06	0.000236	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—AVP—alcohol dependence	5.06e-06	0.000232	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—WASF1—alcohol dependence	5.05e-06	0.000231	CbGpPWpGaD
Escitalopram—Urticaria—Citalopram—alcohol dependence	5.04e-06	5.96e-05	CcSEcCtD
Escitalopram—CHRM1—Signaling Pathways—WASF1—alcohol dependence	5.03e-06	0.000231	CbGpPWpGaD
Escitalopram—Abdominal pain—Citalopram—alcohol dependence	5.02e-06	5.93e-05	CcSEcCtD
Escitalopram—Body temperature increased—Citalopram—alcohol dependence	5.02e-06	5.93e-05	CcSEcCtD
Escitalopram—CYP3A4—Biological oxidations—POMC—alcohol dependence	5e-06	0.000229	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—WASF1—alcohol dependence	4.96e-06	0.000227	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—HTR2A—alcohol dependence	4.95e-06	0.000227	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CHRM2—alcohol dependence	4.95e-06	0.000227	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ADH7—alcohol dependence	4.94e-06	0.000226	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CHRM2—alcohol dependence	4.94e-06	0.000226	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CHRM2—alcohol dependence	4.86e-06	0.000223	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NPY—alcohol dependence	4.83e-06	0.000221	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GGT2—alcohol dependence	4.73e-06	0.000217	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ADH1B—alcohol dependence	4.71e-06	0.000216	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—AVP—alcohol dependence	4.68e-06	0.000215	CbGpPWpGaD
Escitalopram—Hypersensitivity—Citalopram—alcohol dependence	4.68e-06	5.52e-05	CcSEcCtD
Escitalopram—CHRM1—Signaling by GPCR—AVP—alcohol dependence	4.67e-06	0.000214	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CRH—alcohol dependence	4.66e-06	0.000213	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR1B—alcohol dependence	4.66e-06	0.000213	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—AVP—alcohol dependence	4.6e-06	0.000211	CbGpPWpGaD
Escitalopram—Asthenia—Citalopram—alcohol dependence	4.56e-06	5.38e-05	CcSEcCtD
Escitalopram—HRH1—Signaling Pathways—OPRM1—alcohol dependence	4.55e-06	0.000208	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—OPRM1—alcohol dependence	4.53e-06	0.000208	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—HTR2A—alcohol dependence	4.5e-06	0.000206	CbGpPWpGaD
Escitalopram—Pruritus—Citalopram—alcohol dependence	4.49e-06	5.3e-05	CcSEcCtD
Escitalopram—CYP3A4—Metabolism—ADH1A—alcohol dependence	4.47e-06	0.000205	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—OPRM1—alcohol dependence	4.46e-06	0.000204	CbGpPWpGaD
Escitalopram—Diarrhoea—Citalopram—alcohol dependence	4.34e-06	5.13e-05	CcSEcCtD
Escitalopram—CYP2D6—Metabolism—ADH1B—alcohol dependence	4.33e-06	0.000198	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—HTR2A—alcohol dependence	4.29e-06	0.000197	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—HTR2A—alcohol dependence	4.28e-06	0.000196	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—HTR2A—alcohol dependence	4.21e-06	0.000193	CbGpPWpGaD
Escitalopram—Dizziness—Citalopram—alcohol dependence	4.2e-06	4.96e-05	CcSEcCtD
Escitalopram—HRH1—Signaling Pathways—NPY—alcohol dependence	4.18e-06	0.000192	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NPY—alcohol dependence	4.17e-06	0.000191	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NPY—alcohol dependence	4.11e-06	0.000188	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DRD4—alcohol dependence	4.07e-06	0.000187	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR1B—alcohol dependence	4.04e-06	0.000185	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CRH—alcohol dependence	4.04e-06	0.000185	CbGpPWpGaD
Escitalopram—Vomiting—Citalopram—alcohol dependence	4.04e-06	4.77e-05	CcSEcCtD
Escitalopram—CHRM1—Signaling Pathways—HTR1B—alcohol dependence	4.02e-06	0.000184	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CRH—alcohol dependence	4.02e-06	0.000184	CbGpPWpGaD
Escitalopram—Rash—Citalopram—alcohol dependence	4e-06	4.73e-05	CcSEcCtD
Escitalopram—Dermatitis—Citalopram—alcohol dependence	4e-06	4.72e-05	CcSEcCtD
Escitalopram—Headache—Citalopram—alcohol dependence	3.98e-06	4.7e-05	CcSEcCtD
Escitalopram—ADRA1A—Signaling Pathways—HTR1B—alcohol dependence	3.96e-06	0.000181	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CRH—alcohol dependence	3.96e-06	0.000181	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—POMC—alcohol dependence	3.96e-06	0.000181	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MAOB—alcohol dependence	3.9e-06	0.000179	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HTR2A—alcohol dependence	3.9e-06	0.000179	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CNR1—alcohol dependence	3.89e-06	0.000178	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HTR2A—alcohol dependence	3.89e-06	0.000178	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HTR2A—alcohol dependence	3.82e-06	0.000175	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ADH4—alcohol dependence	3.8e-06	0.000174	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DRD2—alcohol dependence	3.79e-06	0.000174	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR7—alcohol dependence	3.79e-06	0.000174	CbGpPWpGaD
Escitalopram—Nausea—Citalopram—alcohol dependence	3.77e-06	4.45e-05	CcSEcCtD
Escitalopram—HTR2C—Signaling by GPCR—POMC—alcohol dependence	3.59e-06	0.000165	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MAOB—alcohol dependence	3.59e-06	0.000164	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD4—alcohol dependence	3.53e-06	0.000162	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD4—alcohol dependence	3.52e-06	0.000161	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD4—alcohol dependence	3.46e-06	0.000159	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—POMC—alcohol dependence	3.43e-06	0.000157	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—POMC—alcohol dependence	3.42e-06	0.000157	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CNR1—alcohol dependence	3.37e-06	0.000154	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—POMC—alcohol dependence	3.36e-06	0.000154	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CNR1—alcohol dependence	3.36e-06	0.000154	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALDH2—alcohol dependence	3.32e-06	0.000152	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CNR1—alcohol dependence	3.31e-06	0.000151	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD2—alcohol dependence	3.29e-06	0.000151	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR7—alcohol dependence	3.29e-06	0.000151	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD2—alcohol dependence	3.28e-06	0.00015	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR7—alcohol dependence	3.28e-06	0.00015	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ADH7—alcohol dependence	3.23e-06	0.000148	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR7—alcohol dependence	3.23e-06	0.000148	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD2—alcohol dependence	3.23e-06	0.000148	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AVP—alcohol dependence	3.19e-06	0.000146	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.19e-06	0.000146	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—POMC—alcohol dependence	3.11e-06	0.000143	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—POMC—alcohol dependence	3.1e-06	0.000142	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GGT2—alcohol dependence	3.1e-06	0.000142	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—POMC—alcohol dependence	3.05e-06	0.00014	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALDH2—alcohol dependence	3.05e-06	0.00014	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.83e-06	0.00013	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GOT2—alcohol dependence	2.82e-06	0.000129	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AVP—alcohol dependence	2.77e-06	0.000127	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AVP—alcohol dependence	2.76e-06	0.000126	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AVP—alcohol dependence	2.72e-06	0.000124	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR2A—alcohol dependence	2.66e-06	0.000122	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP2E1—alcohol dependence	2.65e-06	0.000121	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GOT2—alcohol dependence	2.59e-06	0.000119	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP2E1—alcohol dependence	2.44e-06	0.000112	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GOT1—alcohol dependence	2.43e-06	0.000112	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GGT1—alcohol dependence	2.43e-06	0.000112	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MAOB—alcohol dependence	2.35e-06	0.000107	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR2A—alcohol dependence	2.3e-06	0.000105	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR2A—alcohol dependence	2.3e-06	0.000105	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR2A—alcohol dependence	2.26e-06	0.000103	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GOT1—alcohol dependence	2.24e-06	0.000103	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GGT1—alcohol dependence	2.24e-06	0.000103	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MAOA—alcohol dependence	2.18e-06	9.99e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—POMC—alcohol dependence	2.12e-06	9.72e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.12e-06	9.69e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MAOA—alcohol dependence	2.01e-06	9.19e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.99e-06	9.14e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—POMC—alcohol dependence	1.84e-06	8.42e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—POMC—alcohol dependence	1.83e-06	8.4e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—POMC—alcohol dependence	1.8e-06	8.27e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GOT2—alcohol dependence	1.7e-06	7.77e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.59e-06	7.3e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GOT1—alcohol dependence	1.46e-06	6.71e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GGT1—alcohol dependence	1.46e-06	6.71e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—POMC—alcohol dependence	1.42e-06	6.51e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—EP300—alcohol dependence	1.41e-06	6.45e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MAOA—alcohol dependence	1.31e-06	6.01e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—POMC—alcohol dependence	1.31e-06	5.98e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—EP300—alcohol dependence	1.22e-06	5.59e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—EP300—alcohol dependence	1.22e-06	5.57e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—EP300—alcohol dependence	1.2e-06	5.48e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—EP300—alcohol dependence	9.42e-07	4.32e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—EP300—alcohol dependence	8.67e-07	3.97e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—POMC—alcohol dependence	8.54e-07	3.91e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—EP300—alcohol dependence	5.67e-07	2.6e-05	CbGpPWpGaD
